Susanna Mathe
Neurology · Richmond, VANPI 1508837238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 17.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,773 and has fallen 98.3% since, to $30 in 2025.
Across 111 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$323
- Sanofi$188
- EMD Serono, Inc.$181
- AbbVie$162
- CSL Behring$97
- Biogen$84
- plus $828 from 25 others
What the payments were for
- Speaking & faculty fees$412%
- Food & beverage$1,82398%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 21 | $323 |
| Sanofi | 9 | $188 |
| EMD Serono, Inc. | 15 | $181 |
| AbbVie(2 entities) | 9 | $162 |
| CSL Behring | 5 | $97 |
| Biogen | 5 | $84 |
| Grifols USA, LLC | 4 | $74 |
| Genentech USA, Inc. | 4 | $69 |
| Medtronic | 1 | $66 |
| Eisai Inc. | 3 | $58 |
| Sunovion Pharmaceuticals Inc. | 3 | $50 |
| Greenwich Biosciences, Inc. | 3 | $45 |
| Acorda Therapeutics, Inc | 3 | $41 |
| AstraZeneca | 2 | $39 |
| UCB, Inc. | 2 | $37 |
| Tanabe Pharma America, Inc. | 1 | $35 |
| Lilly USA, LLC | 3 | $34 |
| Promius Pharma LLC | 2 | $34 |
| Livanova USA, Inc. | 2 | $32 |
| Amgen | 2 | $27 |
| Mallinckrodt Enterprises LLC | 2 | $26 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Abbott | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
| Adamas Pharmaceuticals, Inc. | 1 | $12 |
| Amneal Pharmaceuticals LLC | 1 | $12 |
How this compares
$1,864 in reported general payments places this provider in the 55th percentile of 474 neurology providers in Virginia.
Other neurology in Richmond
- Catherine HamRichmond$603K
- Daniel HardyRichmond$382K
- Myla GoldmanRichmond$132K
- Alan SchulmanRichmond$104K
- Warren FeltonRichmond$96K
- John WittmanRichmond$61K
- Matthew BoyceRichmond$56K
- Leslie CloudRichmond$46K
- Jonathan BekensteinRichmond$37K
- Jessica LehositRichmond$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.